FDA-Inspected Site

ProSolus Inc

3 FDA inspections are on record for ProSolus Inc in Miami, United States.

483· Form 483 issued

Miami, United States · Last updated July 10, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-07-25.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
21 Jul 2025 – 25 Jul 2025Human Drugs483View 483 →
27 Feb 2019 – 6 Mar 2019Human DrugsClean
21 Apr 2016 – 26 Apr 2016Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

25 Jul 2025
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Vivin George, Kara J Wright

25 Jul 2025
21 CFR 211.180(e)(1)

Review of representative number of batches

Cited by Vivin George, Kara J Wright

25 Jul 2025
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Vivin George, Kara J Wright

26 Apr 2016
21 CFR 211.165(e)

Test methods

Cited by Richard A Lyght

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind ProSolus Inc's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat